Artículos de revistas sobre el tema "Human primary liver cancer"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Human primary liver cancer".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Zajkowska, Monika y Barbara Mroczko. "Chemokines in Primary Liver Cancer". International Journal of Molecular Sciences 23, n.º 16 (9 de agosto de 2022): 8846. http://dx.doi.org/10.3390/ijms23168846.
Texto completoTakamoto, Takeshi y Masatoshi Makuuchi. "Precision surgery for primary liver cancer". Cancer Biology & Medicine 16, n.º 3 (1 de agosto de 2019): 475–85. http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0194.
Texto completoChrista, Laurence, Marie-Thérèse Simon, Jean-Pierre Flinois, Rolf Gebhardt, Christian Brechot y Chantal Lasserre. "Overexpression of glutamine synthetase in human primary liver cancer". Gastroenterology 106, n.º 5 (mayo de 1994): 1312–20. http://dx.doi.org/10.1016/0016-5085(94)90024-8.
Texto completoLiu, Yewei, Shuncong Wang, Xiaohui Zhao, Yuanbo Feng, Guy Bormans, Johan Swinnen, Raymond Oyen, Gang Huang, Yicheng Ni y Yue Li. "Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation". Diagnostics 10, n.º 2 (31 de enero de 2020): 78. http://dx.doi.org/10.3390/diagnostics10020078.
Texto completoMaki, Harufumi, Yoshikuni Kawaguchi, Junichi Arita, Nobuhisa Akamatsu, Junichi Kaneko, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Yasushi Harihara y Norihiro Kokudo. "Real-time confocal laser endomicroscopic evaluation of primary liver cancer based on human liver autofluorescence". Journal of Surgical Oncology 115, n.º 2 (4 de noviembre de 2016): 151–57. http://dx.doi.org/10.1002/jso.24491.
Texto completoChenivesse, Xavier, Dominique Franco y Christian Bréchot. "MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis". Journal of Hepatology 18, n.º 2 (enero de 1993): 168–72. http://dx.doi.org/10.1016/s0168-8278(05)80243-0.
Texto completoKung, Janet W. C., Ian S. Currie, Stuart J. Forbes y James A. Ross. "Liver Development, Regeneration, and Carcinogenesis". Journal of Biomedicine and Biotechnology 2010 (2010): 1–8. http://dx.doi.org/10.1155/2010/984248.
Texto completoLiu, Nian, Zhipeng Meng, Guiyu Lou, Weiping Zhou, Xiaoqiong Wang, Yunfeng Zhang, Lisheng Zhang et al. "Hepatocarcinogenesis in FXR−/− Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression". Molecular Endocrinology 26, n.º 5 (1 de mayo de 2012): 775–85. http://dx.doi.org/10.1210/me.2011-1383.
Texto completoGong, Yongling. "Therapy response of Chinese herbal medicine in primary liver cancer." Journal of Clinical Oncology 33, n.º 3_suppl (20 de enero de 2015): 488. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.488.
Texto completoFranko, Andras, Sonja Hartwig, Jörg Kotzka, Marc Ruoß, Andreas K. Nüssler, Alfred Königsrainer, Hans-Ulrich Häring, Stefan Lehr y Andreas Peter. "Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells". Nutrients 11, n.º 8 (3 de agosto de 2019): 1795. http://dx.doi.org/10.3390/nu11081795.
Texto completoLeroy, Kaat, Cícero Júlio Silva Costa, Alanah Pieters, Bruna dos Santos Rodrigues, Raf Van Campenhout, Axelle Cooreman, Andrés Tabernilla, Bruno Cogliati y Mathieu Vinken. "Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines". International Journal of Molecular Sciences 22, n.º 22 (10 de noviembre de 2021): 12187. http://dx.doi.org/10.3390/ijms222212187.
Texto completoAdachi, Y., H. Yamamoto, F. Itoh, Y. Hinoda, Y. Okada y K. Imai. "Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers". Gut 45, n.º 2 (1 de agosto de 1999): 252–58. http://dx.doi.org/10.1136/gut.45.2.252.
Texto completoKrishnamurthy, Shivani, David Gilot, Seong Beom Ahn, Vincent Lam, Joo-Shik Shin, Gilles Jackie Guillemin y Benjamin Heng. "Involvement of Kynurenine Pathway in Hepatocellular Carcinoma". Cancers 13, n.º 20 (15 de octubre de 2021): 5180. http://dx.doi.org/10.3390/cancers13205180.
Texto completoLee, Ai Qi, Yan Li y Zhiyuan Gong. "Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology". Cancers 13, n.º 20 (14 de octubre de 2021): 5148. http://dx.doi.org/10.3390/cancers13205148.
Texto completoLee, Ai Qi, Yan Li y Zhiyuan Gong. "Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology". Cancers 13, n.º 20 (14 de octubre de 2021): 5148. http://dx.doi.org/10.3390/cancers13205148.
Texto completoBroutier, Laura, Gianmarco Mastrogiovanni, Monique MA Verstegen, Hayley E. Francies, Lena Morrill Gavarró, Charles R. Bradshaw, George E. Allen et al. "Human primary liver cancer–derived organoid cultures for disease modeling and drug screening". Nature Medicine 23, n.º 12 (13 de noviembre de 2017): 1424–35. http://dx.doi.org/10.1038/nm.4438.
Texto completoGoubran, Mariam, Weiwei Wang, Stanislav Indik, Alexander Faschinger, Shawn T. Wasilenko, Jasper Bintner, Eric J. Carpenter et al. "Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis". Viruses 14, n.º 5 (24 de abril de 2022): 886. http://dx.doi.org/10.3390/v14050886.
Texto completoGoubran, Mariam, Weiwei Wang, Stanislav Indik, Alexander Faschinger, Shawn T. Wasilenko, Jasper Bintner, Eric J. Carpenter et al. "Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis". Viruses 14, n.º 5 (24 de abril de 2022): 886. http://dx.doi.org/10.3390/v14050886.
Texto completoRajput, Ashwani, Ekta Agarwal, Premila Leiphrakpam, Michael G. Brattain y Sanjib Chowdhury. "Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer". ISRN Hepatology 2013 (21 de abril de 2013): 1–9. http://dx.doi.org/10.1155/2013/206875.
Texto completoÁgoston, Emese Irma, Balazs Acs, Zoltan Herold, Krisztina Fekete, Janina Kulka, Akos Nagy, Dorottya Mühl et al. "Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation". Genes 13, n.º 4 (25 de marzo de 2022): 589. http://dx.doi.org/10.3390/genes13040589.
Texto completoRingehan, Marc, Jane A. McKeating y Ulrike Protzer. "Viral hepatitis and liver cancer". Philosophical Transactions of the Royal Society B: Biological Sciences 372, n.º 1732 (11 de septiembre de 2017): 20160274. http://dx.doi.org/10.1098/rstb.2016.0274.
Texto completoWang, Haichuan, Diego F. Calvisi y Xin Chen. "Organoids for the Study of Liver Cancer". Seminars in Liver Disease 41, n.º 01 (enero de 2021): 019–27. http://dx.doi.org/10.1055/s-0040-1719176.
Texto completoBesbes, Samaher, Shahid Shah, Iman Al-dybiat, Shahsoltan Mirshahi, Helene Helfer, Haythem Najah, Caroline Fourgeaud et al. "Thrombopoietin Secretion by Human Ovarian Cancer Cells". International Journal of Cell Biology 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/1873834.
Texto completoZhang, Guangzhi, Kiandokht Bashiri, Mark Kneteman, Kevan Cave, Youngkee Hong, John R. Mackey, Harvey J. Alter y Andrew L. Mason. "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease". Journal of Oncology 2020 (27 de enero de 2020): 1–9. http://dx.doi.org/10.1155/2020/8958192.
Texto completoWadkin, James C. R., Daniel A. Patten, Sivesh K. Kamarajah, Emma L. Shepherd, Vera Novitskaya, Fedor Berditchevski, David H. Adams, Chris J. Weston y Shishir Shetty. "CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma". American Journal of Physiology-Gastrointestinal and Liver Physiology 313, n.º 2 (1 de agosto de 2017): G138—G149. http://dx.doi.org/10.1152/ajpgi.00411.2016.
Texto completoGrossman, Julie G., Timothy M. Nywening, Brian Belt, Elizabeth Pittman, Andrew Giorgi, Ahlers Michael, William G. Hawkins et al. "The role of inflammatory monocytes in human metastatic colorectal cancer." Journal of Clinical Oncology 33, n.º 3_suppl (20 de enero de 2015): 624. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.624.
Texto completoYang, Hai-Yan, Hao-Ling Liu, Lan-Tian Tian, Rui-Peng Song, Xuan Song, Da-Long Yin, Ying-Jian Liang et al. "Expression and prognostic value of ING3 in human primary hepatocellular carcinoma". Experimental Biology and Medicine 237, n.º 4 (abril de 2012): 352–61. http://dx.doi.org/10.1258/ebm.2011.011346.
Texto completoYu, Jianing, Yuanyuan Hong, Pei Zhihua, Tiancheng Han, Song Xiaofeng, Xue Song, Wang Xiaoqing, Zhang Zhuo, Weizhi Chen y Ji He. "DNA methylation profile in unknown cancer origin identification: A multi-class classification model." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e13554-e13554. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13554.
Texto completoSharma, Rajesh. "Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018". Japanese Journal of Clinical Oncology 50, n.º 12 (28 de julio de 2020): 1370–79. http://dx.doi.org/10.1093/jjco/hyaa130.
Texto completoUllman, Nicholas A., Luis I. Ruffolo, Katherine M. Jackson, Alexander Chacon, Rachel Jewell, Mary Georger, Brian A. Belt y David Linehan. "Association of CXCR2+ granulocytic myeloid derived suppressor cells with the development of cholangiocarcinoma: A possible target for intervention." Journal of Clinical Oncology 38, n.º 4_suppl (1 de febrero de 2020): 565. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.565.
Texto completoDuchamp, Olivier, Gael Krysa, Loic Morgand, Hugo Quillery, Robin Artus, Maxime Ramelet, Jeremy Odillard et al. "Abstract 1654: Mouse models of hepatocellular carcinoma: A comprehensive and functional preclinical platform for immunotherapy research". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1654. http://dx.doi.org/10.1158/1538-7445.am2022-1654.
Texto completoHlady, Ryan y Keith Robertson. "Genetic and Epigenetic Heterogeneity in Normal Liver Homeostasis and Its Implications for Liver Disease and Hepatocellular Cancer". Seminars in Liver Disease 38, n.º 01 (febrero de 2018): 041–50. http://dx.doi.org/10.1055/s-0037-1621712.
Texto completoLi, Shipeng, Wenfeng Han, Qichen He, Wei Zhang y Youcheng Zhang. "Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory". Contrast Media & Molecular Imaging 2022 (1 de agosto de 2022): 1–8. http://dx.doi.org/10.1155/2022/6533628.
Texto completoKamaraju, Sailaja, Jill Depke, Janice Povletich, Adam Currey y Elizabeth Weil. "Cutaneous Metastasis due to Breast Cancer in a Patient with Primary Biliary Cirrhosis: A Case Report". Case Reports in Oncology 9, n.º 3 (8 de noviembre de 2016): 718–25. http://dx.doi.org/10.1159/000452145.
Texto completoSahu, Biswajyoti, Päivi Pihlajamaa, Kaiyang Zhang, Kimmo Palin, Saija Ahonen, Alejandra Cervera, Ari Ristimäki, Lauri A. Aaltonen, Sampsa Hautaniemi y Jussi Taipale. "Human cell transformation by combined lineage conversion and oncogene expression". Oncogene 40, n.º 36 (23 de julio de 2021): 5533–47. http://dx.doi.org/10.1038/s41388-021-01940-0.
Texto completoKukla, David A. y Salman R. Khetani. "Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine". Seminars in Liver Disease 41, n.º 03 (17 de junio de 2021): 368–92. http://dx.doi.org/10.1055/s-0041-1731016.
Texto completoNeal, Gordon E. "Further circumstantial evidence for the involvement of aflatoxin in primary liver cancer?" Human & Experimental Toxicology 13, n.º 9 (septiembre de 1994): 603–4. http://dx.doi.org/10.1177/096032719401300904.
Texto completoLin, Longfei, Lei Yan, Yuling Liu, Changhai Qu, Jian Ni y Hui Li. "The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017". Liver Cancer 9, n.º 5 (2020): 563–82. http://dx.doi.org/10.1159/000508568.
Texto completoKim, Tae Suk, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi y Yuri Cho. "Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1". International Journal of Molecular Sciences 22, n.º 18 (17 de septiembre de 2021): 10027. http://dx.doi.org/10.3390/ijms221810027.
Texto completoLaes, Jean-François, Luis Antonio Parada, Bertil Johansson, Göran Levan, Claude Szpirer y Josiane Szpirer. "Alterations of P19ARF in Rodent Hepatoma Cell Lines but not in Human Primary Liver Cancer". Cancer Genetics and Cytogenetics 117, n.º 2 (marzo de 2000): 118–24. http://dx.doi.org/10.1016/s0165-4608(99)00157-0.
Texto completoYuzhalin, Arseniy E., Su Yin Lim, Alex N. Gordon-Weeks, Roman Fischer, Benedikt M. Kessler, Dihua Yu y Ruth J. Muschel. "Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases". American Journal of Physiology-Gastrointestinal and Liver Physiology 317, n.º 5 (1 de noviembre de 2019): G625—G639. http://dx.doi.org/10.1152/ajpgi.00014.2019.
Texto completoLiu, Yuchen, Xiaohui Wang y Yingzi Yang. "Hepatic Hippo signaling inhibits development of hepatocellular carcinoma". Clinical and Molecular Hepatology 26, n.º 4 (1 de octubre de 2020): 742–50. http://dx.doi.org/10.3350/cmh.2020.0178.
Texto completoFang, Xingbao, Yongping Xu, Kezhi Li, Peiwan Liu, Hong Zhang, Yang Jiang, Jianwei Tang y Yuehong Li. "Exosomal lncRNA PCAT1 Promotes Tumor Circulating Cell-Mediated Colorectal Cancer Liver Metastasis by Regulating the Activity of the miR-329-3p/Netrin-1-CD146 Complex". Journal of Immunology Research 2022 (31 de agosto de 2022): 1–13. http://dx.doi.org/10.1155/2022/9916228.
Texto completoChen, Ivy X., Vikash P. Chauhan, Jessica Posada, Mei R. Ng, Michelle W. Wu, Pichet Adstamongkonkul, Peigen Huang, Neal Lindeman, Robert Langer y Rakesh K. Jain. "Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer". Proceedings of the National Academy of Sciences 116, n.º 10 (30 de enero de 2019): 4558–66. http://dx.doi.org/10.1073/pnas.1815515116.
Texto completoOyama, Astushi, Hidenori Shiraha, Daisuke Uchida, Masaya Iwamuro, Hironari Kato, Akinobu Takaki, Fusao Ikeda et al. "A Phase I/Ib trial of Ad-REIC in liver cancer: study protocol". Future Oncology 15, n.º 31 (noviembre de 2019): 3547–54. http://dx.doi.org/10.2217/fon-2019-0115.
Texto completoBortolami, Marina, Daniela Molè, Chiara Carlotto, Andromachi Kotsafti, Milena Minotto, Romilda Cardin y Fabio Farinati. "Sa1717 mTOR and LC3 Gene and Protein Expression in Chronic Liver Disease and in Primary and Secondary Human Liver Cancer". Gastroenterology 148, n.º 4 (abril de 2015): S—1019. http://dx.doi.org/10.1016/s0016-5085(15)33485-5.
Texto completoIbrahim, Nisreen S., Anthoula Lazaris, Miran Rada, Stephanie K. Petrillo, Laurent Huck, Sabah Hussain, Shaida Ouladan et al. "Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM)". Cancers 12, n.º 1 (20 de diciembre de 2019): 35. http://dx.doi.org/10.3390/cancers12010035.
Texto completoHu, Kaiweng. "Recombinant adenoviral human p53 gene infusion in treatment of malignant pleural effusions and malignant ascites." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 3027. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3027.
Texto completoSanghvi, Viraj, Aleksander Rust, Josef Leibold, Scott Lowe, Agnes Viale, John Chodera, Ronald C. Hendrickson, Elisa de Stanchina y Hans-Guido Wendel. "Abstract PO029: Targeting non-canonical Hippo pathway in NRF2-mutant liver cancer". Clinical Cancer Research 28, n.º 17_Supplement (1 de septiembre de 2022): PO029. http://dx.doi.org/10.1158/1557-3265.liverca22-po029.
Texto completoSelvaggi, Federico, Teresa Catalano, Roberto Cotellese y Gitana Maria Aceto. "Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents". Cancers 14, n.º 8 (10 de abril de 2022): 1912. http://dx.doi.org/10.3390/cancers14081912.
Texto completo